Home > Insider Trading > Filing (0001209191-17-048495)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1593034	Endo International Plc	ENDP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1639314	J Terrance Coughlin	C/O Endo International Plc First Fl, Minerva House, Simmonscourt Rd Ballsbridge, Dublin L2	Evp, Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Stock Incentive Plan Restricted Stock Units (Rsu)	Acquisiton	2017-08-10	112,500	$0.00	181,369	No	4	A	Direct
Ordinary Shares	Acquisiton	2017-08-10	20,000	$7.70	140,582	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	2015 Stock Incentive Plan Stock Options (NQ)	Acquisiton	2017-08-10	255,681	$0.00	255,681	$7.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
255,681		2027-08-10	No	4	A	Direct

Footnotes

Upon each vesting date, each vested restricted stock unit automatically converts into one (1) ordinary share of Endo International plc. These restricted stock units (RSUs) generally vest 33 1/3% per year on each of August 10, 2018, August 10, 2019 and August 10, 2020. Upon vesting, we consider the underlying RSUs to be expired.
These securities were granted to Mr. Coughlin in consideration of his services as Executive Vice President and Chief Operating Officer of Endo International plc.
Represents the right to buy ordinary shares, par value $0.0001 per share, of Endo International plc.
These stock options are generally exercisable 33 1/3% per year on each of August 10, 2018, August 10, 2019 and August 10, 2020.